Home/Filings/4/0001235802-23-000072
4//SEC Filing

Pauls Dietrich John 4

Accession 0001235802-23-000072

CIK 0001401040other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:34 PM ET

Size

4.9 KB

Accession

0001235802-23-000072

Insider Transaction Report

Form 4
Period: 2023-06-23
Pauls Dietrich John
DirectorPresident & CEO
Transactions
  • Purchase

    Voting Common Shares, no par value per share

    2023-06-23$3.91/sh+12,787$49,99768,591 total
Footnotes (1)
  • [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1
  • filerCIK 0001760123

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:34 PM ET
Size
4.9 KB